You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NAMS Exercise Disclosure
Kooij Louise Frederika · SEC Form 4 · Filed Jun 24, 2026
Exercise
Calculated transaction value
$0
Kooij Louise Frederika Chief Accounting Officer
NAMS
Transaction date
Jun 22, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 2 days later
NAMS daily price context
Close on/before transaction
$30.82
Jun 22, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Option (right to buy) on Ordinary Shares
- Quantity / price
- 15,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-281062
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.66M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Newamsterdam Pharma Co N.v. NAMS | Exercise | Jun 22, 2026 | $272.5K |
| Newamsterdam Pharma Co N.v. NAMS | Exercise | Jun 22, 2026 | $178.5K |
| Newamsterdam Pharma Co N.v. NAMS | Sale | Jun 22, 2026 | $1.2M |
| Newamsterdam Pharma Co N.v. NAMS | Sale | Jun 22, 2026 | $9.22K |
| Newamsterdam Pharma Co N.v. NAMS | Exercise | Jun 22, 2026 | $0 |
| Newamsterdam Pharma Co N.v. NAMS Current | Exercise | Jun 22, 2026 | $0 |